Mitigation of Staphylococcus aureus-mediated surgical site infections with ir photoactivated TiO2 coatings on Ti

Asem Aboelzahab1, Abdul-Majeed Azad, Shawn Dolan

  • 1Department of Bioengineering, The University of Toledo, Toledo, OH 43606-3390, USA.

Insights

Infrared-activated titanium dioxide nanocoatings on implants show over 90% Staphylococcus aureus cell death. This innovative approach effectively combats surgical site infections, reducing risks and improving patient outcomes.

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Infectious Disease Research

Background:

  • Surgical site infections (SSIs) caused by Staphylococcus aureus (including MRSA and MSSA) prolong hospitalization and increase costs.
  • Staphylococcus aureus poses significant health risks, potentially leading to mortality.
  • Titanium dioxide (TiO(2)) exhibits photoactivity, demonstrating potent antibacterial properties against various bacterial strains.

Purpose of the Study:

  • To investigate the efficacy of infrared (IR)-photoactivated TiO(2) nanocoatings on titanium implants for mitigating SSIs.
  • To evaluate the antibacterial performance of TiO(2) nanocoatings against Staphylococcus aureus upon IR laser activation.

Main Methods:

  • TiO(2) nanocoatings were applied to implantable materials (Ti mesh and plate) using aqueous plasma electrodeposition.
  • The antibacterial efficacy of the nanocoatings was assessed following brief activation with an IR laser source.
  • Bacterial cell viability (necrosis) was quantified after exposure to the activated nanocoatings.

Main Results:

  • Over 90% necrosis of Staphylococcus aureus cells was observed within 30 minutes.
  • This high efficacy was achieved after only a 30-second exposure to the IR-activated titania-coated implants.
  • The study demonstrated significant mitigation of harmful bacterial growth.

Conclusions:

  • IR-photoactivated TiO(2) nanocoatings present a promising strategy for preventing SSIs.
  • This nanotechnology offers a novel approach to enhance implant safety and reduce infection-related complications.
  • The findings highlight the potential of functionalized biomaterials in combating bacterial infections in clinical settings.